Cancer glossary
Median survival: what this number means and how to read it
What median survival means in cancer statistics, why it is not one person’s life expectancy, and what median overall survival and ‘median not reached’ mean.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
Median survival is the length of time from diagnosis or the start of treatment at which half of the patients in a group are still alive. The number describes a group of people in a study, not the outlook for any one person.
How it appears in your report
You are more likely to see a median in articles, guidelines and your doctor’s explanations than in a discharge summary:
- ‘Median overall survival (mOS) — N months’ — half of the patients in the group lived longer than this.
- ‘Median progression-free survival (mPFS) — N months’ — at this point, the disease had not yet started to grow in half of the patients.
- ‘Median not reached’ — more than half of the participants were still alive or progression-free at the time of analysis.
- It is often followed by ‘95% CI’ — the confidence interval, the range in which the true value most likely lies.
What it means
A median is the middle value, not an average and not a limit. If the median is 2 years, half of the group lived less and half lived longer, and some patients live much longer than the median.
| Measure | What is counted |
|---|---|
| Overall survival | time until death from any cause |
| Progression-free survival | time the disease does not get worse, that is, until progression |
| Disease-free survival | time until the disease returns after curative treatment |
The US National Cancer Institute describes median overall survival as one way to see how well a new treatment works in a clinical trial. Statistics are collected over years, so they reflect treatment that patients received in the past.
Does it affect treatment
Medians help compare options: for example, which regimen held the disease back longer in studies of a similar situation. But trials select patients by strict criteria, and your case may differ in stage, markers, line of therapy and general condition. How these numbers apply to you is for your treating doctor to judge.
Questions to ask your doctor
- Which study is this median from, and were its participants similar to me?
- Is this overall survival or progression-free survival?
- What in my results might make the outlook better or worse than average?
How to read study results is covered in the article on clinical trials.
Sources
- Median overall survival — NCI Dictionary of Cancer Terms — National Cancer Institute
- Median survival — Glossary — Canadian Cancer Society
- Understanding Cancer Prognosis — National Cancer Institute, 2024
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
